Covestor Ltd Has $37,000 Position in The Cooper Companies, Inc. (NASDAQ:COO)

Covestor Ltd grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 144.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 338 shares of the medical device company’s stock after acquiring an additional 200 shares during the period. Covestor Ltd’s holdings in Cooper Companies were worth $37,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Cooper Companies by 303.0% in the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after purchasing an additional 17,367,502 shares during the last quarter. Capital World Investors boosted its position in shares of Cooper Companies by 301.7% during the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock valued at $573,657,000 after acquiring an additional 4,246,519 shares during the last quarter. Janus Henderson Group PLC lifted its position in Cooper Companies by 279.8% in the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after buying an additional 2,532,186 shares during the last quarter. Bessemer Group Inc. lifted its position in Cooper Companies by 305.2% in the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock worth $203,013,000 after buying an additional 1,507,049 shares during the last quarter. Finally, Swedbank AB bought a new stake in Cooper Companies in the first quarter valued at approximately $139,246,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total value of $2,625,049.20. Following the transaction, the chief financial officer now directly owns 6,614 shares in the company, valued at approximately $700,422.60. This trade represents a 78.94 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 72.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock worth $27,637,427 in the last ninety days. 2.00% of the stock is owned by company insiders.

Cooper Companies Price Performance

Shares of COO stock opened at $99.63 on Friday. The Cooper Companies, Inc. has a 52-week low of $82.21 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The firm has a market capitalization of $19.84 billion, a P/E ratio of 55.50, a P/E/G ratio of 2.20 and a beta of 0.99. The stock has a 50 day moving average price of $106.83 and a 200 day moving average price of $97.93.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. Cooper Companies’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period last year, the company earned $0.84 EPS. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Wall Street Analyst Weigh In

COO has been the topic of several research analyst reports. Morgan Stanley boosted their target price on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 10th. StockNews.com raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Thursday. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Piper Sandler upped their price target on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.